Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 225

Netradyne accelerates to $150m series C

SoftBank Vision Fund 2 led a series C round for the driver safety technology developer at a valuation of almost $1bn that also featured M12.

Jul 16, 2021

Kriya Therapeutics engineers $100m series B

Patient Square Capital led a series B round for the gene therapy developer that included existing corporate investor Dexcel Pharma.

Jul 16, 2021

Mann takes on Takeda Ventures role

Takeda Ventures has brought on Mann as a senior partner who draws on extensive life sciences-focused venture capital experience.

Jul 16, 2021

Mighty Buildings constructs $22m round

Klaff Realty was among the investors in the construction technology developer’s latest round, which took its overall funding to $100m.

Jul 16, 2021

Yello enlists WayUp for merger deal

University and diversity-focused recruitment group Yello is merging with its corporate-backed counterpart in a bid to drive DEI hiring strategy.

Jul 16, 2021

Kriya engineers $100m series B

Patient Square Capital has led a series B round for the Stanford-linked gene therapy developer, which previously collected $80.5m in May last year.

Jul 16, 2021

Daily Deal Round Up: July 15, 2021

Clean medicine developer Genexa roped in Unilever for its $60m series A round while Krafton led storytelling platform developer Pratilipi's $48m series D.

Jul 15, 2021

Emerging Leaders Q&A – Andrea Course, Shell Ventures

Q&A with Andrea Course, venture principal, Shell Ventures

Jul 15, 2021

Cybereason picks up $275m

Softbank helped the XDR cybersecurity software provider secure crossover financing at a valuation likely to have exceeded $3bn.

Jul 15, 2021

Amplitude anticipates direct listing

Tencent-backed digital analytics software provider Amplitude has reportedly filed confidentially for a direct listing, weeks after raising cash at a $4bn valuation.

Jul 15, 2021
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here